Tristel Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB00B07RVT99
GBP
3.68
0.03 (0.82%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 7.96%

 
3

The company has declared Positive results for the last 4 consecutive quarters

4

With ROE of 21.84%, it has a fair valuation with a 5.50 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 175 Million (Small Cap)

stock-summary
P/E

25.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

382.87%

stock-summary
Debt Equity

-0.35

stock-summary
Return on Equity

23.44%

stock-summary
Price to Book

5.32

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1.52%
0%
1.52%
6 Months
4.55%
0%
4.55%
1 Year
-6.84%
0%
-6.84%
2 Years
-20.0%
0%
-20.0%
3 Years
2.22%
0%
2.22%
4 Years
-12.38%
0%
-12.38%
5 Years
-24.9%
0%
-24.9%

Tristel Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.96%
EBIT Growth (5y)
7.04%
EBIT to Interest (avg)
5.99
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.34
Sales to Capital Employed (avg)
1.17
Tax Ratio
15.95%
Dividend Payout Ratio
102.01%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.29%
ROE (avg)
16.89%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
5.50
EV to EBIT
19.70
EV to EBITDA
15.40
EV to Capital Employed
7.81
EV to Sales
3.72
PEG Ratio
2.15
Dividend Yield
381.94%
ROCE (Latest)
39.66%
ROE (Latest)
21.84%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Tristel Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jun'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jun 2023 is 15.76% vs 0.32% in Jun 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jun 2023 is 350.00% vs -72.97% in Jun 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'23",
        "Jun'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "36.00",
          "val2": "31.10",
          "chgp": "15.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.00",
          "val2": "6.90",
          "chgp": "15.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-2.50",
          "chgp": "96.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.50",
          "val2": "1.00",
          "chgp": "350.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.70%",
          "val2": "134.40%",
          "chgp": "1.63%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Jun'23stock-summary
Jun'23
Jun'22
Change(%)
Net Sales
36.00
31.10
15.76%
Operating Profit (PBDIT) excl Other Income
8.00
6.90
15.94%
Interest
0.20
0.20
Exceptional Items
-0.10
-2.50
96.00%
Consolidate Net Profit
4.50
1.00
350.00%
Operating Profit Margin (Excl OI)
150.70%
134.40%
1.63%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Jun 2023 is 15.76% vs 0.32% in Jun 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Jun 2023 is 350.00% vs -72.97% in Jun 2022

stock-summaryCompany CV
About Tristel Plc stock-summary
stock-summary
Tristel Plc
Pharmaceuticals & Biotechnology
Tristel Plc is a United Kingdom-based manufacturer of infection prevention and contamination control products. The Company's technology is a chlorine dioxide formulation. The Company operates through three segments: Human Healthcare, Animal Healthcare and Contamination Control. The Human Healthcare segment is engaged in the manufacture, development and sale of infection control and hygiene products, which include products that are used primarily for infection control in hospitals. The segments products are marketed under the brand, Tristel. The Animal Healthcare segment relates to manufacture and sale of disinfection and cleaning products into veterinary and animal welfare sectors. The segments products are marketed under the brand, Anistel. The Contamination Control segment addresses the pharmaceutical and personal care product manufacturing industries. The segments products are marketed under the brand, Crystel. Its manufacturing facility is located in Newmarket, Cambridgeshire.
Company Coordinates stock-summary
Company Details
Lynx Business Park,Fordham Road , SNAILWELL None : CB8 7NY
stock-summary
Tel: 44 1638 72150044 1638 721500
stock-summary
Registrar Details